EASIX and m-EASIX predict severe cytokine release syndrome and overall survival after CAR T-cell therapy

This publication has 20 references indexed in Scilit:

• IL-10 plus the EASIX score predict bleeding events after anti-CD19 CAR T-cell therapy
  Annals of Hematology, 2023
• Pre-lymphodepletion & infusion endothelial activation and stress index as predictors of clinical outcomes in CAR-T therapy for B-cell lymphoma
  Blood Cancer Journal, 2023
• Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells
  Blood Advances, 2021
• Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell Transplantation
  HemaSphere, 2020
• Taming the beast: CRS and ICANS after CAR T-cell therapy for ALL
  Bone Marrow Transplantation, 2020
• Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma
  Blood Advances, 2020
• Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
  The Lancet, 2020
• ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
  Transplantation and Cellular Therapy, 2019
• EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis
  The Lancet Haematology, 2017
• Engraftment syndrome: double-edged sword of hematopoietic cell transplants
  Bone Marrow Transplantation, 2015